EUROPE COUGH SYRUP MARKET 2022-2028

 

 

TABLE OF CONTENTS

1. EUROPE COUGH SYRUP MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON THE COUGH SYRUP MARKET

2.2. KEY INSIGHTS

2.2.1. INCREASING DEMAND FOR HERBAL COUGH SYRUPS

2.2.2. COMPANIES PROVIDE SUGAR-FREE COUGH SYRUPS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1. MERGERS & ACQUISITIONS

2.6.2. DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. INCREASING CHRONIC RESPIRATORY DISEASES

2.7.2. RISE IN OLDER POPULATION

2.8. MARKET CHALLENGES

2.8.1. OVERDOSE RISK

2.8.2. STRICT GOVERNMENT REGULATIONS AND RESTRICTIONS

2.9. MARKET OPPORTUNITIES

2.9.1. INCREASE IN CHILD-FRIENDLY COUGH SYRUP FLAVORS

2.9.2. GROWING PREFERENCE FOR HOMEOPATHIC COUGH SYRUPS

2.9.3. SPECIAL PEDIATRIC COUGH SYRUPS

3. EUROPE COUGH SYRUP MARKET OUTLOOK - BY PRODUCT TYPE

3.1. COUGH SUPPRESSANTS/ANTITUSSIVES

3.2. COMBINATION MEDICATIONS

3.3. EXPECTORANTS

4. EUROPE COUGH SYRUP MARKET OUTLOOK - BY AGE GROUP

4.1. ADULT

4.2. PEDIATRIC

5. EUROPE COUGH SYRUP MARKET OUTLOOK - BY DISTRIBUTION CHANNEL

5.1. RETAIL PHARMACY

5.2. HOSPITAL PHARMACY

5.3. ONLINE PHARMACY

6. EUROPE COUGH SYRUP MARKET – COUNTRY OUTLOOK

6.1. UNITED KINGDOM

6.2. GERMANY

6.3. FRANCE

6.4. SPAIN

6.5. ITALY

6.6. REST OF EUROPE

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. ACELLA PHARMACEUTICALS LLC

7.3. ASTRAZENECA PLC

7.4. CIPLA LIMITED

7.5. DABUR INDIA LTD

7.6. GLAXOSMITHKLINE

7.7. GLENMARK PHARMACEUTICALS LIMITED

7.8. JOHNSON AND JOHNSON

7.9. MERCK KGAA

7.10. NOVARTIS INTERNATIONAL AG

7.11. PFIZER INC

7.12. PROCTOR AND GAMBLE CO

7.13. RECKITT BENCKISER GROUP PLC

7.14. SANOFI SA

7.15. THE HIMALAYA DRUG COMPANY

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

         

 

LIST OF TABLES

TABLE 1: EUROPE COUGH SYRUP MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: THE COUNTRIES WITH THE LARGEST PERCENTAGE OF TOTAL POPULATION OVER 65 YEARS IN 2020

TABLE 4: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)

TABLE 5: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2022-2028 (IN $ MILLION)

TABLE 6: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2022-2028 (IN $ MILLION)

TABLE 7: EUROPE COUGH SYRUP MARKET, BY COUNTRY OUTLOOK, 2022-2028 (IN $ MILLION)

 

 

LIST OF FIGURES

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: EUROPE COUGH SYRUP MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)

FIGURE 3: EUROPE COUGH SYRUP MARKET, BY COUGH SUPPRESSANTS/ANTITUSSIVES, 2022-2028 (IN $ MILLION)

FIGURE 4: EUROPE COUGH SYRUP MARKET, BY COMBINATION MEDICATIONS, 2022-2028 (IN $ MILLION)

FIGURE 5: EUROPE COUGH SYRUP MARKET, BY EXPECTORANTS, 2022-2028 (IN $ MILLION)

FIGURE 6: EUROPE COUGH SYRUP MARKET, BY AGE GROUP, 2021 & 2028 (IN %)

FIGURE 7: EUROPE COUGH SYRUP MARKET, BY ADULT, 2022-2028 (IN $ MILLION)

FIGURE 8: EUROPE COUGH SYRUP MARKET, BY PEDIATRIC, 2022-2028 (IN $ MILLION)

FIGURE 9: EUROPE COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL, 2021 & 2028 (IN %)

FIGURE 10: EUROPE COUGH SYRUP MARKET, BY RETAIL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 11: EUROPE COUGH SYRUP MARKET, BY HOSPITAL PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 12: EUROPE COUGH SYRUP MARKET, BY ONLINE PHARMACY, 2022-2028 (IN $ MILLION)

FIGURE 13: EUROPE COUGH SYRUP MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)

FIGURE 14: UNITED KINGDOM COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 15: GERMANY COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 16: FRANCE COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 17: SPAIN COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 18: ITALY COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

FIGURE 19: REST OF EUROPE COUGH SYRUP MARKET 2022-2028 (IN $ MILLION)

 

 

 

MARKET OUTLOOK

Triton Market Research’s report estimates that the cough syrup market in Europe will advance at a compound annual growth rate of 3.20% in revenue during 2022-2028. Germany, Italy, the United Kingdom, Spain, France, and the Rest of Europe form the market in this region.

Chronic obstructive pulmonary disorder (COPD) and chronic bronchitis are majorly prevalent in France. As per estimates, air pollution is responsible for the majority of premature deaths in the country. Moreover, it has surged the risks of lung cancer, COPD, bronchitis, and emphysema. Lung cancer is the second-highest cause of death in the country. Furthermore, air pollution levels in the past few years have surged significantly in Paris, leading to issues such as chronic bronchitis and asthma. Therefore, as mentioned above, these factors are fueling the demand for cough syrups, supporting the cough syrup market’s growth.

Likewise, the prevalence of COPD is significant in Spain, affecting more than 10% of the population. Moreover, respiratory disorders such as asthma are becoming more common owing to the rise in air pollution. In 2020, around 2.3 million people were diagnosed with chronic allergies in the nation. Furthermore, the nation’s older population is highly susceptible to respiratory diseases. Therefore, the rise in the older population will drive the demand for cough syrups, fueling the cough syrup market on a growth path.

 

Get more Insights into the Europe Cough Syrup Market:

 

https://www.tritonmarketresearch.com/reports/europe-cough-syrup-market

 

 

COMPETITIVE OUTLOOK

The major companies in the cough syrup market include AstraZeneca Plc, Dabur India Ltd, Abbott Laboratories, Cipla Limited, Pfizer Inc, and GlaxoSmithKline.

 

 

SEGMENTATION

1.     ABBOTT LABORATORIES

2.     ACELLA PHARMACEUTICALS LLC

3.     ASTRAZENECA PLC

4.     CIPLA LIMITED

5.     DABUR INDIA LTD

6.     GLAXOSMITHKLINE

7.     GLENMARK PHARMACEUTICALS LIMITED

8.     JOHNSON AND JOHNSON

9.     MERCK KGAA

10. NOVARTIS INTERNATIONAL AG

11. PFIZER INC

12. PROCTOR AND GAMBLE CO

13. RECKITT BENCKISER GROUP PLC

14. SANOFI SA

15. THE HIMALAYA DRUG COMPANY